Traphaco JSC (STC:TRA) EBIT: ₫389,392 Mil (TTM As of Mar. 2026)


STC:TRA Traphaco JSC STC:TRA
83 GF Score
Price ₫77,900.00
GF Value ₫92,290.93
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Traphaco JSC EBIT?

Traphaco JSC STC:TRA -0.13% 83 EBIT is ₫389,392 Mil as of Mar. 2026. GuruFocus rates STC:TRA with a GF Score™ of 83/100 and a GF Value™ of ₫92,290.93 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Traphaco JSC's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₫96,101 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₫389,392 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Traphaco JSC's annualized ROC % for the quarter that ended in Mar. 2026 was 23.29%. Traphaco JSC's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 41.21%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Traphaco JSC's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 13.57%.


Traphaco JSC  (STC:TRA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Traphaco JSC's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=371589.36 * ( 1 - 27.31% )/( (1155360.93 + 1163711.175)/ 2 )
=270108.305784/1159536.0525
=23.29 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2322602.817 - 461777.776 - ( 705464.111 - max(0, 633384.597 - 1745129.014+705464.111))
=1155360.93

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2409821.319 - 526906.832 - ( 719203.312 - max(0, 835102.595 - 1837568.7+719203.312))
=1163711.175

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Traphaco JSC's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=384404.38/( ( (430725.552 + max(529574.244, 0)) + (431058.403 + max(474412.865, 0)) )/ 2 )
=384404.38/( ( 960299.796 + 905471.268 )/ 2 )
=384404.38/932885.532
=41.21 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(354270.647 + 562573.893 + 112886.641) - (461777.776 + 0 + 38379.161)
=529574.244

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(380322.355 + 575036.082 + 129018.23) - (526906.832 + 0 + 83056.97)
=474412.865

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Traphaco JSC's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=389391.911/2868757.210
=13.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Traphaco JSC EBIT Related Terms


Traphaco JSC EBIT Historical Data

* Premium members only.

The historical data trend for Traphaco JSC's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Traphaco JSC EBIT Chart

Traphaco JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 336,143.28 369,543.85 364,607.76 328,521.52 354,514.31

Traphaco JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62,227.29 94,137.15 97,089.11 102,064.56 96,101.10

STC:TRA vs ZTS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Traphaco JSC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Traphaco JSC EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Traphaco JSC's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Traphaco JSC's EV-to-EBIT falls into.


STC:TRA
83GF Score
Traphaco JSC STC:TRA
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Traphaco JSC EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫389,392 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₫389,392 Mil mean?
Traphaco JSC (STC:TRA) has a EBIT of ₫389,392 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Traphaco JSC.
Is Traphaco JSC's EBIT too high?
Traphaco JSC's current EBIT is ₫389,392 Mil. Overall, Traphaco JSC has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Traphaco JSC's EBIT compare to ZTS?
Traphaco JSC's EBIT of ₫389,392 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Traphaco JSC. Traphaco JSC's current EBIT is ₫389,392 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Traphaco JSC stock overvalued right now?
Based on GuruFocus' analysis, Traphaco JSC (STC:TRA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫92,290.93, compared to a current price of ₫77,900.00 — trading 15.6% below its estimated fair value. The current EBIT is ₫389,392 Mil. Traphaco JSC's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Traphaco JSC (STC:TRA), the current EBIT is ₫389,392 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Traphaco JSC (STC:TRA) Overvalued in 2026?

Based on GuruFocus' analysis, Traphaco JSC stock appears to be undervalued. The current stock price of ₫77,900.00 is trading 15.6% below its estimated GF Value™ of ₫92,290.93. GuruFocus considers Traphaco JSC to be Modestly Undervalued.

Key valuation signals for STC:TRA:

  • EBIT: ₫389,392 Mil
  • GF Value™: ₫92,290.93 vs. price of ₫77,900.00 (15.6% below fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the STC:TRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Traphaco JSC Business Description

Address 75 Yen Ninh Street, Quan Thanh Ward, Ba Dinh District, Ha Noi City, VNM
Traphaco JSC is engaged in the production and trading of pharmaceuticals, chemicals, and medical supplies and equipment. The company's products are used for nourishing the body, the Skeletal system, for hair, for eyes, the Nervous system, the Respiratory system, and Other groups.
83GF Score

Get the complete analysis for STC:TRA

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫77,900.00
Price
₫92,290.93
GF Value